Babcock & Wilcox Enterprises Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.86
Target price
04.11.21
€0.90
Performance (%)
666.08%
End price
05.11.21
€6.55
Summary
This prediction ended on 05.11.21 with a price of €6.55. With a performance of 666.08% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Babcock & Wilcox Enterprises Inc | -12.984% | -12.984% | 827.684% | 68.930% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by krebskrebs for this prediction
In the thread Babcock & Wilcox Enterprises Inc diskutieren
In the thread Trading Babcock & Wilcox Enterprises Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten